Top Markets
#1 Black Phoenix Black Phoenix +166.58%
#2 Islamic Coin Islamic Coin +158.26%
#3 Glidr Glidr +84.34%
#4 Test Test +23.21%
#5 Cryptopia Cryptopia +21.17%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.42%
#7 Quantum Resistant Ledger Quantum Resistant Ledger +15.72%
#8 DOVU DOVU +11.66%
#9 MarsCoin MarsCoin +11.25%
#10 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +11.04%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
NewCardio, Inc. NewCardio, Inc.

NewCardio, Inc.

NWCI
Classifica tra le azioni #42209
NewCardio, Inc. is a company dedicated to cardiac diagnostics and related... NewCardio, Inc. is a company dedicated to cardiac diagnostics and related services. Its primary objective is the research, creation, and market introduction of exclusive software platform technologies. These innovations are designed for two main applications: the non-invasive diagnosis and continuous monitoring of cardiovascular diseases (CVD), and the assessment of cardiac safety for experimental drugs. The company's underlying technology analyzes the heart's electrical activity in real-time and in three dimensions, using data gathered from the body's surface via standard 12-lead electrocardiogram (ECG) electrodes. NewCardio is also actively developing several products. QTinno, for instance, is an automated solution for cardiac safety, utilizing algorithms to automatically measure, analyze, and report on collected ECGs, thereby streamlining traditional manual or semi-automated methods. Another product, CardioBip, is a mobile ECG system for remote transmission, comprising a portable recording and transmitting device along with web-based software that receives, processes, and interprets the data. Furthermore, the company is progressing with my3KG, a software application intended to provide a comprehensive method for evaluating cardiac electrical activity across both time and space. NewCardio, Inc. was founded in 2004 and is headquartered in Branchburg, New Jersey.
Prezzo delle azioni
$0.0001
Ultima sincronizzazione: 2026-08-11
Capitalizzazione di mercato
$3.32K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia NewCardio, Inc. (NWCI)

Categoria

Healthcare
Ricavi di NewCardio, Inc. (NWCI)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di NewCardio, Inc., i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per NewCardio, Inc. da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US